Immunochemical properties and pathological relevance of anti-β2-glycoprotein I antibodies of different avidity

International Immunology

Volumn 23, Issue 8, 2011, Pages 511-518

  Žager, Urška ^a   Irman, Špela ^a   Lunder, Mojca ^b   Škarabot, Miha ^b,c   Muševič, Igor ^b,c   Hodnik, Vesna ^b   Anderluh, Gregor ^b   Čučnik, Saša ^a   Kveder, Tanja ^a   Rozman, Blaž ^a   Božič, Borut ^a,b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

Affinity; Annexin A5; Antiphospholipid antibody; Atomic force microscopy; Surface plasmon resonance

Indexed keywords

BETA2 GLYCOPROTEIN 1; PHOSPHOLIPID;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ATOMIC FORCE MICROSCOPY; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOCHEMISTRY; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROTEIN INTERACTION; SURFACE PLASMON RESONANCE;

EID: 79960718455     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxr043     Document Type: Article

References (39)

1. Espinosa, G. and Cervera, R. 2009. Morbidity and mortality in the antiphospholipid syndrome. Curr. Opin. Pulm. Med. 15:413.
2. Danowski, A., Kickler, T. S. and Petri, M. 2006. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. J. Rheumatol. 33:1775.
3. Tincani, A., Casu, C., Cartella, S., Ziglioli, T. and Cattaneo, R. 2010. Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations. Reumatismo 62:65.
4. Alijotas-Reig, J., Ferrer-Oliveras, R., Rodrigo-Anoro, M. J., Farran-Codina, I., Cabero-Roura, L. and Vilardell-Tarres, M. 2010. Anti-beta(2)-glycoprotein-I and anti-phosphatidylserine antibodies in women with spontaneous pregnancy loss. Fertil. Steril. 93:2330.
5. Cucnik, S., Kveder, T., Rozman, B. and Bozic, B. 2004. Binding of high avidity anti-beta 2-glycoprotein I antibodies. Rheumatology 43:1353.
6. Giles, I. P., Isenberg, D. A., Latchman, D. S. and Rahman, A. 2003. How do antiphospholipid antibodies bind beta2-glycoprotein I? Arthritis Rheum. 48:2111.
7. Iverson, G. M., Matsuura, E., Victoria, E. J., Cockerill, K. A. and Linnik, M. D. 2002. The orientation of beta2GPI on the plate is important for the binding of anti-beta2GPI autoantibodies by ELISA. J. Autoimmun. 18:289.
8. Cucnik, S., Kveder, T., Krizaj, I., Rozman, B. and Bozic, B. 2004. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Ann. Rheum. Dis. 63:1478.
9. Vlachoyiannopoulos, P. G., Petrovas, C., Tektonidou, M., Krilis, S. and Moutsopoulos, H. M. 1998. Antibodies to beta 2-glycoprotein-I: urea resistance, binding specificity, and association with thrombosis. J. Clin. Immunol. 18:380.
10. Gharavi, A. E. and Reiber, H. 1996. Affinity and avidity of autoantibodies. In Peter, J. B. and Shoenfeld, Y., eds, Autoantibodies. p.13. Elsevier Science B.V., Amsterdam.
11. Reddel, S. W. and Krilis, S. A. 1999. Testing for and clinical significance of anticardiolipin antibodies. Clin. Diagn. Lab. Immunol. 6:775.
12. de Laat, B., Dersken, R. H. and de Groot, P. G. 2006. High-avidity anti-β2-glycoprotein I antibodies highly correlate with thrombosis in contrast to low-avidity anti-β2-glycoprotein I antibodies. J. Throm. Haemost. 4:1619.
13. Cucnik, S., Kveder, T., Ulcova Gallova, Z. et al. 2011. Avidity of anti-beta2-glycoprotein I antibodies in patients with or without anti-phospholipid syndrome. A collaborative study in the frame of the European forum on antiphospholipid antibodies. Lupus, in press.
14. de Laat, B., Derksen, R. H., Urbanus, R. T. and de Groot, P. G. 2005. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 105:1540.
15. Giannakopoulos, B., Passam, F., Ioannou, Y. and Krilis, S. A. 2009. How we diagnose the antiphospholipid syndrome. Blood 113:985.
16. Rand, J. H., Wu, X. X., Andree, H. A. et al. 1997. Pregnancy loss in the antiphospholipid-antibody syndrome-a possible thrombogenic mechanism. N. Engl. J. Med. 337:154.
17. Del Papa, N., Sheng, Y. H., Raschi, E. et al. 1998. Human β2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-β2-glycoprotein I antibodies. J. Immunol. 160:5572.
18. Di Simone, N., Raschi, E., Testoni, C. et al. 2005. Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro. Ann. Rheum. Dis. 64:462.
19. Lean, S. Y., Ellery, P., Ivey, L. et al. 2006. The effects of tissue factor pathway inhibitor and anti-β2-glycoprotein I IgG on thrombin generation. Haematologica 91:1360.
20. Irman, S., Miha, S., Igor, M., Rozman, B. and Bozic, B. 2009. In vitro model of annexin A5 crystallization on natural phospholipid bilayers observed by atomic force microscopy. Autoimmunity 42:414.
21. 2-glycoprotein I antibodies on crystalline annexin A5 on phospholipid bilayers, as observed by atomic force microscopy. eJIFCC 21.
22. Irman, S., Skarabot, M., Musevic, I., Rozman, B. and Bozic, B. 2011. The use of atomic force microscopy to study the pathologic effects of anti-annexin autoantibodies. J. Autoimmun. 36:98.
23. Rand, J. H., Wu, X. X., Andree, H. A. et al. 1998. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin V binding to phospholipids: a "Lupus Procoagulant" phenomenom. Blood 92:1652.
24. Rand, J. H., Wu, X. X., Quinn, A. S. and Taatjes, D. J. 2008. Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome. Lupus 17:922.
25. Cucnik, S., Bozic, B., Kveder, T., Tomsic, M. and Rozman, B. 2005. Avidity of anti-beta2-glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndrome. Ann. N. Y. Acad. Sci. 1051:141.
26. Ichikawa, K., Tsutsumi, A., Atsumi, T. et al. 1999. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies. Arthritis. Rheum. 42:2461.
27. Cucnik, S., Krizaj, I., Rozman, B., Kveder, T. and Bozic, B. 2004. Concomitant isolation of protein C inhibitor and unnicked beta2-glycoprotein I. Clin. Chem. Lab. Med. 42:171.
28. Metzger, J., von Landenberg, P., Kehrel, M., Buhl, A., Lackner, K. J. and Luppa, P. B. 2007. Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies. Clin. Chem. 53:1137.
29. Regnault, V., De Maistre, E., Wahl, D. and Lecompte, T. 2000. Monovalent binding of autoantibodies to beta2-glycoprotein I, detected using surface plasmon resonance at low antigen density. Br. J. Haematol. 109:187.
30. Ambrozic, A., Avicin, T., Ichikawa, K. et al. 2002. Anti-beta(2)-glycoprotein I antibodies in children with atopic dermatitis. Int. Immunol. 14:823.
31. Agar, C., van Os, G. M., Mörgelin, M. et al. 2010. Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood 116:1336.
32. Schultz, D. R. 1997. Antiphospholipid antibodies: basic immunology and assays. Semin. Arthritis Rheum. 26:724.
33. Tincani, A., Spatola, L., Prati, E. et al. 1996. The anti-beta2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species' evolution. J. Immunol. 157:5732.
34. Sheng, Y., Kandiah, D. A. and Krilis, S. A. 1998. Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphos-pholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity. J. Immunol. 161:2038.
35. Arvieux, J., Renaudineau, Y., Mane, I., Perraut, R., Krilis, S. A. and Youinou, P. 2002. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the anti-phospholipid syndrome. Thromb. Haemost. 87:599.
36. Gamsjaeger, R., Johs, A., Gries, A. et al. 2005. Membrane binding of β2-glycoprotein I can be described by a two-state reaction model: an atomic force microscopy and surface plasmon resonance study. Biochem. J. 389:665.
37. Richter, R. P., Lai Kee Him, J., Tessier, B., Tessier, C. and Brisson, A. 2005. On the kinetics of adsorption and two dimensional self-assembly of annexin A5 on supported lipid bilayers. Biophys. J. 89:3372.
38. Reviakine, I., Bergsma-Schutter, W., Mozorov, A. N. and Brisson, A. 2001. Two-dimensional crystallization of annexin A5 on phospholipid bilayers and monolayers: a solid-solid phase transition between crystal forms. Langmuir 17:1680.
39. Reviakine, I., Bergsma-Schutter, W., Marezes-Dubut, C., Govorukhina, N. and Brisson, A. 2000. Surface topography of the p3 and p6 annexin v crystal forms determined by atomic force microscopy. J. Struct. Biol. 131:234.